阿司匹林与尼莫地平在偏头痛治疗中的效果比较  

Effect comparison of Aspirin and Nimodipine in the treatment of migraine

作　　者：盛飞[1] 李庭毅[1] 李文辉[1] SHENG Fei;LI Ting-yi;LI Wen-hui(Department of Neurology, Xiaogan Central Hospital, Hubei Province, Xiaogan 432000, China)

机构地区：[1]湖北省孝感市中心医院神经内科

出　　处：《中国当代医药》2019年第16期62-64,共3页China Modern Medicine

摘　　要：目的对阿司匹林与尼莫地平治疗偏头痛中的效果进行观察及分析。方法选取2016年8月~2018年8月在我院接受治疗的100例偏头痛患者作为研究对象,按照治疗方案的不同分成研究组和参照组,每组各50例。参照组实施尼莫地平治疗,研究组实施阿司匹林治疗方案,比较两组的治疗效果,包括观察治疗总有效率、并发症发生率、复发率等指标。结果研究组的治疗总有效率(96.00%)高于参照组(80.00%),差异有统计学意义(P<0.05);研究组的并发症总发生率(4.00%)明显的低于参照组(18.00%),差异有统计学意义(P<0.05);研究组的复发率(2.00%)显著低于参照组(18.00%),差异有统计学意义(P<0.05)。结论在治疗偏头痛时,应用尼莫地平和阿司匹林均可获得一定的成效,但相较于尼莫地平而言,阿司匹林的治疗效果更显著。Objective To observe and analyze the effects of Aspirin and Nimodipine in the treatment of migraine.Methods A total of 100 migraine patients who treated in our hospital from August 2016 to August 2018 were selected as the study subjects. According to the different treatment regimens, the patients were divided into study group and reference group, 50 cases in each group. Among them, patients in the reference group were treated with Nimodipine, while in the study group, Aspirin was adopted. The therapeutic effects of the two groups were compared, including observation of overall treatment effectiveness rate, incidence of complications, and recurrence rate. Results The total effectiveness rate in the study group was 96.00%, higher than that in the reference group accounting for 80.00% with significant difference(P<0.05). The total incidence of complications in the study group was 4.00%, greatly lower than that in the study group accounting for 18.00% with statistical difference(P< 0.05). The recurrence rate in the study group was2.00%, significantly lower compared with that in the reference group accounting for 18.00% with significant difference(P<0.05). Conclusion In the treatment of migraine, both Nimodipine and Aspirin can obtain certain effects, but the effect is more remarkable used by Aspirin than Nimodipine.

关 键 词：阿司匹林 尼莫地平 偏头痛 治疗效果 比较观察 

分 类 号：R747.2[医药卫生—神经病学与精神病学]